These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 1825181

  • 1. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
    Willman CL, Stewart CC, Longacre TL, Head DR, Habbersett R, Ziegler SF, Perlmutter RM.
    Blood; 1991 Feb 15; 77(4):726-34. PubMed ID: 1825181
    [Abstract] [Full Text] [Related]

  • 2. Differential expression and regulation of the c-src and c-fgr protooncogenes in myelomonocytic cells.
    Willman CL, Stewart CC, Griffith JK, Stewart SJ, Tomasi TB.
    Proc Natl Acad Sci U S A; 1987 Jul 15; 84(13):4480-4. PubMed ID: 2440024
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells.
    Ashmun RA, Look AT, Roberts WM, Roussel MF, Seremetis S, Ohtsuka M, Sherr CJ.
    Blood; 1989 Feb 15; 73(3):827-37. PubMed ID: 2465043
    [Abstract] [Full Text] [Related]

  • 4. c-sis but not c-fos gene expression is lineage specific in human myeloid cells.
    Sariban E, Mitchell T, Rambaldi A, Kufe DW.
    Blood; 1988 Feb 15; 71(2):488-93. PubMed ID: 3276363
    [Abstract] [Full Text] [Related]

  • 5. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR, Chang Y, Ruan GR, Qin YZ, Lai YY, Shi HX, Wang YZ, Li LD, Jiang B, Li JL.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb 15; 34(2):98-103. PubMed ID: 23611213
    [Abstract] [Full Text] [Related]

  • 6. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA.
    Am J Clin Pathol; 1998 Feb 15; 109(2):211-20. PubMed ID: 9583894
    [Abstract] [Full Text] [Related]

  • 7. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen IM, Whittaker MH, Griffith BB, Licht JD.
    Blood; 1994 Jul 01; 84(1):244-55. PubMed ID: 7517211
    [Abstract] [Full Text] [Related]

  • 8. Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.
    Re F, Arpinati M, Testoni N, Ricci P, Terragna C, Preda P, Ruggeri D, Senese B, Chirumbolo G, Martelli V, Urbini B, Baccarani M, Tura S, Rondelli D.
    Exp Hematol; 2002 Feb 01; 30(2):126-34. PubMed ID: 11823047
    [Abstract] [Full Text] [Related]

  • 9. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N, Musto P, D'Arena G, Melillo L, Carella AM, Petrilli MP, Sanpaolo G, Carotenuto M.
    Haematologica; 1998 May 01; 83(5):392-7. PubMed ID: 9658721
    [Abstract] [Full Text] [Related]

  • 10. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R, Saulle E, Militi S, Sposi NM, Gualtiero M, Mauro N, Mancini M, Diverio D, Lo Coco F, Peschle C, Testa U.
    Leukemia; 2003 Jan 01; 17(1):98-113. PubMed ID: 12529666
    [Abstract] [Full Text] [Related]

  • 11. Expression of myeloid Src-family kinases is associated with poor prognosis in AML and influences Flt3-ITD kinase inhibitor acquired resistance.
    Patel RK, Weir MC, Shen K, Snyder D, Cooper VS, Smithgall TE.
    PLoS One; 2019 Jan 01; 14(12):e0225887. PubMed ID: 31790499
    [Abstract] [Full Text] [Related]

  • 12. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia.
    Dubosc-Marchenay N, Lacombe F, Dumain P, Marit G, Montastruc M, Belloc F, Reiffers J.
    Hematol Oncol; 1992 Jan 01; 10(5):235-49. PubMed ID: 1493908
    [Abstract] [Full Text] [Related]

  • 13. Cloning of the murine c-fgr proto-oncogene cDNA and induction of c-fgr expression by proliferation and activation factors in normal bone marrow-derived monocytic cells.
    Yi TL, Willman CL.
    Oncogene; 1989 Sep 01; 4(9):1081-7. PubMed ID: 2674853
    [Abstract] [Full Text] [Related]

  • 14. The proto-oncogene c-fgr is expressed in normal mantle zone B lymphocytes and is developmentally regulated during myelomonocytic differentiation in vivo.
    Link DC, Zutter M.
    Blood; 1995 Jan 15; 85(2):472-9. PubMed ID: 7812001
    [Abstract] [Full Text] [Related]

  • 15. Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cells.
    Bijl JJ, van Oostveen JW, Walboomers JM, Brink AT, Vos W, Ossenkoppele GJ, Meijer CJ.
    Leukemia; 1998 Nov 15; 12(11):1724-32. PubMed ID: 9823947
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.
    Gattei V, Celetti A, Cerrato A, Degan M, De Iuliis A, Rossi FM, Chiappetta G, Consales C, Improta S, Zagonel V, Aldinucci D, Agosti V, Santoro M, Vecchio G, Pinto A, Grieco M.
    Blood; 1997 Apr 15; 89(8):2925-37. PubMed ID: 9108413
    [Abstract] [Full Text] [Related]

  • 18. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
    Porwit-MacDonald A, Ivory K, Wilkinson S, Wheatley K, Wong L, Janossy G.
    Leukemia; 1995 Jul 15; 9(7):1191-8. PubMed ID: 7543174
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. B-lymphoid/myeloid stem cell origin in Ph-positive acute leukemia with myeloid markers.
    Akashi K, Taniguchi S, Nagafuji K, Harada M, Shibuya T, Hayashi S, Gondo H, Niho Y.
    Leuk Res; 1993 Jul 15; 17(7):549-55. PubMed ID: 8326735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.